inhibitors and antagonists of hmgb1 can inhibit the pathogenesis and progression of atherosclerotic disease.

摘要

The use of molecules that modulate the action of HMGBl protein (or molecules having sequence homology) for the preparation of Therapeutic agents to be used for the treatment of atherosclerosis is described.